Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PatientPing Expands Care Coordination Platform into Hospitals and Emergency Departments Nationwide to Identify High Utilizers and Reduce Readmissions
April 10, 2018 -
Cancer biotech Surface Oncology sets terms for $84 million IPO
April 9, 2018 -
Adaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual Meeting
April 6, 2018 -
Unum Therapeutics Announces Closing of IPO and Concurrent Private Placement with Seattle Genetics
April 3, 2018 -
Unum Therapeutics Announces Pricing of Initial Public Offering
March 29, 2018 -
TraceLink Publishes Full Analysis from the Global Drug Supply, Safety and Traceability Report, Industry’s Largest Survey on Life Science Companies’ Readiness for Serialization Deadlines
March 28, 2018 -
Checkmate Pharmaceuticals to Present Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
March 28, 2018 -
Tempest Therapeutics Closes $70 Million Series B Financing
March 28, 2018 -
Hua Medicine Raises $117.4 Million in Series D & Series E Financing
March 27, 2018 -
Cancer biotech Surface Oncology files for a $75 million IPO
March 23, 2018 -
Oviva Diabetes Support scoops annual award at Diabetes UK Conference
March 21, 2018 -
Orchard Therapeutics Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer and General Counsel
March 21, 2018 -
Unum Therapeutics (UNUM) to Raise $75 Million in IPO
March 21, 2018 -
Surface Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of SRF231
March 20, 2018 -
Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals
March 20, 2018 -
Protenus CEO at AMIA 2018 Informatics Summit: Health Systems Can Prevent Drug Diversion With Artificial Intelligence
March 19, 2018 -
Denali Therapeutics Announces First-In-Human Dosing Of Its RIPK1 Inhibitor Clinical Program And The Appointment Of Peter Klein To Board Of Directors
March 19, 2018 -
This Scientist Turned CEO of Caribou Biosciences Wants to Gene-Edit a Way to Cure Cancer
March 16, 2018 -
Adaptimmune’s GSK-partnered T cells trigger responses in solid tumor patients
March 16, 2018 -
Acacia Pharma’s Baremis® Prevents Post-Operative Nausea And Vomiting In High-Risk Patients
March 15, 2018 -
TraceLink Grows Market Position in DACH Region by 215% in 2017
March 12, 2018 -
Orchard Therapeutics Scientific Founder Prof Donald Kohn Recognized with Pediatric Blood and Marrow Transplant Consortium Lifetime Achievement Award
March 9, 2018 -
Froedtert Provides Patients with Symptom Checker from Boston Startup Buoy Health
March 9, 2018 -
China’s Hua Medicine plans $400 million Hong Kong IPO, led by Goldman: Sources
March 9, 2018 -
Surface Oncology and ProBioGen Sign Second Antibody Manufacturing Program
March 8, 2018 -
WuXi Biologics and Adagene Announce Strategic Development and Manufacturing Partnership of New Antibody Therapeutics
March 8, 2018 -
VitalWare’s™ Medical Necessity Edits Now Used Nationwide with New Partnership
March 6, 2018 -
Tiny biotech takes on Glaxo’s $730,000 gene therapy
March 6, 2018 -
OTA Insight’s Rate Intelligence Solutions Now in 20,000 Hotels Worldwide
March 5, 2018 -
Denali Therapeutics Collaborates With Parkinson’s Institute and Clinical Center to Explore New Endpoints for Clinical Studies
March 5, 2018 -
Acacia Pharma Group raises €40m at IPO for US growth
March 2, 2018 -
Cancer immunotherapy biotech Unum Therapeutics files for an $86 million IPO
March 2, 2018 -
TraceLink, Selected by Pioneering German Biotechnlogy Company, to Comply with EU FMD Serialization Regulations
February 28, 2018 -
Cipla ties up with Roche to sell 2 cancer drugs in India
February 28, 2018 -
AllSpire Health GPO Adopts Lumere’s Solutions to Support Value-Based Initiatives
February 27, 2018 -
Cargill, Precision BioSciences team up to develop next generation of low saturate, high oleic canola oil
February 22, 2018 -
Surface Oncology Expands Board of Directors
February 22, 2018 -
Surface Oncology Promotes Jeff Goater to Chief Executive Officer
February 12, 2018 -
Denali Therapeutics and Lonza Pharma & Biotech Announce Exclusive Partnership to Develop and Produce Biologic Medicines
February 8, 2018 -
Zenflow Raises $31.4M in Series A Funding
February 7, 2018 -
Adaptimmune Begins In-house T-Cell Therapy Manufacture at PA Plant
February 6, 2018 -
PatientPing Announces National Collaboration with HCR ManorCare to Improve Health Outcomes
January 30, 2018 -
Menlo Therapeutics Inc. Announces Pricing of Initial Public Offering of Common Stock
January 24, 2018 -
Procured Health Expands Focus, Becomes Lumere
January 24, 2018 -
Aclaris Therapeutics Making Age Spots a Thing of the Past
January 23, 2018 -
Protenus Raises $11M From F-Prime Capital, Kaiser Permanente Ventures
January 22, 2018 -
Cygnus super specialty hospital first to introduce Gastroenterology unit in Kaithal
January 21, 2018 -
VitalWare names Sharon Prill as CMO and Jarrod Heinz as new CFO
January 10, 2018 -
Adaptimmune Gets the Green Light for its New T-cell Cancer Therapy
January 9, 2018 -
Denali Therapeutics and Takeda Collaborate to Develop and Commercialize Therapies for Neurodegenerative Diseases
January 5, 2018 -
Quartet Health just raised $40 million to expand its healthcare platforms
January 4, 2018 -
Paul Stead Joins Adaptimmune as Vice President of Business Development
January 4, 2018 -
Cipla Health to expand consumer health biz with new launches and acquisitions
November 29, 2017 -
Lacey mental health hospital approved for US HealthVest
November 29, 2017 -
Oviva Health brings in $12M for dietary support platform
November 21, 2017 -
Apellis Pharmaceuticals Announces Closing of its Initial Public Offering
November 13, 2017 -
TraceLink acquires ROC IT Solutions
August 29, 2017 -
PatientPing’s Community Comes to Wisconsin Through Partnership with Bellin Health
August 29, 2017 -
VitalWare™ Once Again Named to Inc. Magazine’s 36th Annual List of America’s Fastest-Growing Private Companies
August 28, 2017 -
Stride Health Secures $23.5 Million in Series B Funding
August 22, 2017 -
Artemis Health Secures $16 Million Series B Round to Equip Employers with Actionable Employment Benefits Data
August 16, 2017 -
Orient Speech Therapy Center Ltd. Collaboration First for China
August 11, 2017 -
Orchard Therapeutics hires ex-PTC executive Mark Rothera as new CEO
August 10, 2017 -
PlasmaGen BioSciences raises $25 mn from Eight Roads Ventures, F-Prime
August 2, 2017 -
Protenus Profile: This Baltimore startup is trying to keep your hospital records safe from cyberattacks
August 2, 2017 -
Orchard Therapeutics Announces That OTL-101 Has Received a Rare Paediatric Disease Designation
July 24, 2017 -
Amphora Medical Closes $35.5 Million Series B Financing
July 20, 2017 -
Protenus Extends Series A Funding Round
July 20, 2017 -
Menlo Therapeutics Raises $50M in Series C Financing
July 18, 2017 -
PatientPing partners with ACO in Houston
July 12, 2017 -
Caribou Biosciences Appoints Steven B. Kanner, Ph.D. as Chief Scientific Officer
July 6, 2017 -
US HealthVest Opens Smokey Point Behavioral Hospital
July 6, 2017 -
PatientPing announced a partnership with Georgia-based WellStar Health System
June 28, 2017 -
Genoa Pharmaceuticals Secures $62 Million Series A Financing
May 15, 2017 -
Acacia Pharma announces positive results from its fourth and final pivotal trial of Baremsis™ for the rescue treatment of PONV
February 13, 2017 -
WelbeHealth Announces $15 Million of Funding from F-Prime Capital and .406 Ventures
February 8, 2017 -
PatientPing partners with Hackensack Meridian Health to bring care coordination to health care providers in New Jersey
January 24, 2017 -
US HealthVest opens second Atlanta hospital, serves unmet need for specialized psychiatric care
January 23, 2017 -
Surface Oncology Welcomes Industry Leader Daniel S. Lynch as Chairman of Board of Directors
January 4, 2017 -
Surface Oncology Appoints Robert Ross, MD as Chief Medical Officer
December 15, 2016 -
PatientPing Raises $31.6 Million from Andreessen Horowitz and Leerink Transformation Partners to Accelerate Growth of its National Care Coordination Network
December 6, 2016 -
Surface Oncology CD47 Program Demonstrates Promising Anti-Tumor Activity in Hematological Disease Models
December 2, 2016 -
TraceLink Raises $51.5M Series C to Accelerate Growth
November 30, 2016 -
Surface Oncology Announces First Fully Human CD47 Antibody Entering Clinical Development in 2017
November 8, 2016 -
Turnstone Biologics raises $41.4 Million Series B Financing
November 2, 2016 -
Eywa Pharma announces $30M investment from Eight Roads Ventures, F-Prime Capital and Envestor Ventures
October 18, 2016 -
Iora Health Raises $75 Million Series D Financing
October 13, 2016 -
Akriveia Therapeutics Announces Its Recent Series A Investment By F-Prime Capital Partners
October 12, 2016 -
FierceBiotech names Orchard Therapeutics Limited as one of its “Fierce 15” Biotech Companies of 2016
September 19, 2016 -
With its software, TraceLink capitalizes on drug counterfeiting crackdown
September 11, 2016
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.